In a recent presentation at the Philippine Neurological Association's annual convention, Israeli cardiologist Professor Reuven Zimlichman challenged the common perception of nicotine as the primary cause of smoking-related diseases. Zimlichman, director of The Brunner Cardiovascular Research Institute at Tel Aviv University, asserted that while nicotine is addictive, it is not carcinogenic and does not directly cause heart disease or blood vessel disease.
According to Zimlichman, the real harm from smoking comes from the thousands of chemicals produced by the burning of tobacco, not from nicotine itself. This distinction has important implications for public health strategies aimed at reducing the burden of smoking-related diseases.
Potential of Heated Tobacco Products and Vapes as Harm Reduction Tools
Zimlichman advised Filipino doctors to consider recommending heated tobacco products or vapes to patients who are unable to quit smoking, particularly those with severe cardiovascular disease. These smoke-free products, which deliver nicotine without burning tobacco, have the potential to significantly reduce the exposure to harmful chemicals compared to traditional cigarettes.
Heated tobacco products heat tobacco just enough to release a nicotine-containing aerosol, while vapes heat a nicotine-containing liquid to create a vapor. By eliminating the combustion process, these products can potentially mitigate the health risks associated with smoking.
Evidence Supporting Tobacco Harm Reduction Strategies
Zimlichman cited several studies and real-world examples to support the potential of tobacco harm reduction strategies. A 2021 South Korean study found that switching to smoke-free products was associated with a 23% lower risk of cardiovascular disease, with the reduction mostly attributed to heated tobacco products.
Sweden, which has a long history of widespread use of snus and nicotine pouches, serves as another example of successful tobacco harm reduction. The country has achieved a significant decline in smoking rates and boasts the lowest rate of tobacco-related diseases in the European Union.
The Need for New Approaches in Tobacco Control
Despite decades of implementing traditional tobacco control strategies, the global smoking epidemic persists, with an estimated 1 billion smokers worldwide and 8 million deaths annually from smoking-related diseases. Zimlichman argued that it is time for governments, regulatory agencies, and the medical community to be open to new ideas, such as tobacco harm reduction, to address this public health crisis.
Tobacco harm reduction aims to provide less harmful alternatives to people who are unable or unwilling to quit smoking using currently approved methods. By embracing technological innovations like heated tobacco products and vapes, public health officials and healthcare providers may be able to reach more smokers and help them reduce their exposure to harmful chemicals.
Conclusion
Professor Zimlichman's insights challenge the conventional wisdom surrounding nicotine and its role in smoking-related diseases. By distinguishing between the effects of nicotine and the harmful chemicals produced by tobacco combustion, he highlights the potential of smoke-free products as tools for tobacco harm reduction.
As the global community continues to grapple with the devastating impact of smoking on public health, it is critical to consider new approaches and technologies that can help reduce the burden of smoking-related diseases. While more research is needed to fully understand the long-term effects of heated tobacco products and vapes, the evidence presented by Professor Zimlichman suggests that these products may offer a promising path forward for smokers who are unable to quit using traditional methods.
